Feasibility and signal quality of the Minder® implantable continuous EEG monitoring® system compared to 10-20 scalp electrodes over extended monitoring periods.

Saved in:
Bibliographic Details
Title: Feasibility and signal quality of the Minder® implantable continuous EEG monitoring® system compared to 10-20 scalp electrodes over extended monitoring periods.
Authors: Ganguly TM; Penn Neuroscience Center-Neurology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Lai A; Department of Medicine, St. Vincents Hospital Melbourne, University of Melbourne, Melbourne, Victoria, Australia., Niemiec A; Epiminder Pty Ltd, Melbourne, Victoria, Australia., Cameron T; Epiminder Pty Ltd, Melbourne, Victoria, Australia.; Department of Clinical Neurosciences, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia., Conrad EC; Penn Neuroscience Center-Neurology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Raghupathi R; Penn Neuroscience Center-Neurology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ellis C; Penn Neuroscience Center-Neurology, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Halliday AJ; Department of Medicine, St. Vincents Hospital Melbourne, University of Melbourne, Melbourne, Victoria, Australia.; Department of Clinical Neurosciences, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia., Gillinder L; Queensland Brain Institute, The University of Queensland, St Lucia, Queensland, Australia.; Neurology Department, Princess Alexandra Hospital, Brisbane, Queensland, Australia., Seneviratne U; Department of Medicine, St. Vincents Hospital Melbourne, University of Melbourne, Melbourne, Victoria, Australia.; Department of Neurology, Monash Medical Centre, Melbourne, Victoria, Australia., Kwan P; Neurology Department, Alfred Health, Melbourne, Victoria, Australia.; Department of Neurosciences, Central Clinical School, Alfred Hospital, Monash University, Melbourne, Victoria, Australia.; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia., Perucca P; Department of Medicine, Austin Health, University of Melbourne, Melbourne, Victoria, Australia., McGonigal A; Queensland Brain Institute, The University of Queensland, St Lucia, Queensland, Australia.; Faculty of Medicine, Mater Hospital and Mater Research Institute, Mater Centre for Neurosciences, The University of Queensland, South Brisbane, Queensland, Australia., Vogrin S; Department of Clinical Neurosciences, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia., Fontenot H; Epiminder Pty Ltd, Melbourne, Victoria, Australia., Cook MJ; Department of Medicine, St. Vincents Hospital Melbourne, University of Melbourne, Melbourne, Victoria, Australia.; Epiminder Pty Ltd, Melbourne, Victoria, Australia.; Department of Clinical Neurosciences, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.
Source: Epilepsia [Epilepsia] 2026 May 20. Date of Electronic Publication: 2026 May 20.
Publication Type: Journal Article
Journal Info: Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-1167
DOI:10.1002/epi.70290